GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Silence Therapeutics PLC (NAS:SLN) » Definitions » E10

Silence Therapeutics (Silence Therapeutics) E10 : $-7.92 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Silence Therapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Silence Therapeutics's adjusted earnings per share data for the three months ended in Mar. 2024 was $-0.053. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-7.92 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-10), Silence Therapeutics's current stock price is $20.79. Silence Therapeutics's E10 for the quarter that ended in Mar. 2024 was $-7.92. Silence Therapeutics's Shiller PE Ratio of today is .


Silence Therapeutics E10 Historical Data

The historical data trend for Silence Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silence Therapeutics E10 Chart

Silence Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -21.22 -19.47 -34.16

Silence Therapeutics Quarterly Data
Jun18 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.57 -22.65 -46.89 -34.16 -7.92

Competitive Comparison of Silence Therapeutics's E10

For the Biotechnology subindustry, Silence Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Silence Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Silence Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Silence Therapeutics's Shiller PE Ratio falls into.



Silence Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Silence Therapeutics's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.053/131.6000*131.6000
=-0.053

Current CPI (Mar. 2024) = 131.6000.

Silence Therapeutics Quarterly Data

per share eps CPI Adj_EPS
200806 -12.053 86.600 -18.316
200812 -4.703 87.100 -7.106
200906 -6.530 88.100 -9.754
200912 -7.159 88.900 -10.598
201006 -5.583 90.200 -8.145
201012 -1.591 91.700 -2.283
201106 -2.358 93.500 -3.319
201112 -0.537 95.000 -0.744
201206 -9.565 95.600 -13.167
201212 3.465 97.300 4.686
201306 -0.391 98.000 -0.525
201312 -0.570 99.200 -0.756
201406 -0.584 99.800 -0.770
201412 -0.493 99.900 -0.649
201506 -0.332 100.100 -0.436
201512 -0.148 100.400 -0.194
201606 -0.290 101.000 -0.378
201612 -0.199 102.200 -0.256
201706 -0.303 103.500 -0.385
201712 0.225 105.000 0.282
201806 -0.495 105.900 -0.615
201812 -0.524 107.100 -0.644
201906 -0.437 107.900 -0.533
201912 -0.452 108.500 -0.548
202006 -0.514 108.800 -0.622
202009 -0.427 109.200 -0.515
202012 -0.609 109.400 -0.733
202103 -0.404 109.700 -0.485
202106 -0.551 111.400 -0.651
202109 -0.457 112.400 -0.535
202112 -0.419 114.700 -0.481
202203 -0.340 116.500 -0.384
202206 -0.491 120.500 -0.536
202209 -0.245 122.300 -0.264
202212 -0.479 125.300 -0.503
202303 -0.346 126.800 -0.359
202306 -0.364 129.400 -0.370
202309 -0.275 130.100 -0.278
202312 -0.475 130.500 -0.479
202403 -0.053 131.600 -0.053

Add all the adjusted EPS together and divide 10 will get our e10.


Silence Therapeutics  (NAS:SLN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Silence Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of Silence Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Silence Therapeutics (Silence Therapeutics) Business Description

Traded in Other Exchanges
Address
72 Hammersmith Road, London, GBR, W14 8TH
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risk of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.

Silence Therapeutics (Silence Therapeutics) Headlines

From GuruFocus

Silence Therapeutics Reports First Quarter 2022 Results

By Business Wire Business Wire 05-16-2022

Silence Therapeutics Announces Pricing of Underwritten Offering

By Business Wire Business Wire 08-11-2022